Right to Try Clarification Act

United States117th CongressHR-8440House of Representatives
Updated: Nov 1, 2022

Summary

Right to Try Clarification Act This bill specifies that investigational drugs that are provided directly to individuals from manufacturers without the need for federal regulatory approval (i.e., via the Right to Try pathway) are exempt from restrictions that would otherwise apply under the Controlled Substances Act (e.g., restrictions on the use or possession of schedule I controlled substances).

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

S-4575: Right to Try Clarification Act

Introduced in Senate

  1. Introduced in House

  2. Sponsor introductory remarks on measure. (CR E757)

  3. Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    House of Representatives

  4. Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

    House of Representatives

All available records shown.